Clinical trial

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in…

NCT00227630 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed

Key facts

NCT number NCT00227630
Title Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Official title A Phase II Feasibility Trial of Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Postoperative Radiotherapy in Patients With Malignant Pleural Mesothelioma
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Malignant Mesothelioma
Intervention type Drug, Procedure, Radiation
Interventions cisplatin, pemetrexed disodium, adjuvant therapy, conventional surgery, neoadjuvant therapy, radiation therapy
Enrollment 59
Start date Jul 1, 2005
Primary completion Aug 1, 2007
First posted Sep 28, 2005
Last update posted Jul 18, 2012
Countries Belgium, Italy, Netherlands, United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies